Polymers and oligomers with aggregation-induced emission characteristics for imaging and image-guided therapy

A technology of conjugated polymers and compositions, applied in the direction of organic active ingredients, photodissociation of drugs in the body, active ingredients of heavy metal compounds, etc., can solve problems such as affecting the effect of photodynamic therapy and weakening the ability of singlet oxygen

Inactive Publication Date: 2017-03-01
NAT UNIV OF SINGAPORE +1
View PDF4 Cites 46 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, photosensitizers entrapped in nanoparticles will aggregate due to π–π interactions (such as the widely used commercial photosensitizer porphyrin), which will greatly weaken the ability to generate singlet oxygen, which will ultimately affect photodynamic therapy. Effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polymers and oligomers with aggregation-induced emission characteristics for imaging and image-guided therapy
  • Polymers and oligomers with aggregation-induced emission characteristics for imaging and image-guided therapy
  • Polymers and oligomers with aggregation-induced emission characteristics for imaging and image-guided therapy

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0247] Aggregation-Inducing Luminescent Dyes for Cell Tracking

[0248] The AIE fluorescent agent 4,7-bis[4-(1,2,2-triphenylethenyl)phenyl]benzo-2,1,3-thiadiazole (BTPEBT) was used for long-term cell display The traced surface functionalized green-emitting AIE dots are reported as examples. BTPEBT is an example of a conjugated system that can be used in this patent. A mixture of lipid-poly(ethylene glycol) (PEG) and lipid-PEG-maleimide was selected as the encapsulation matrix, and BTPEBT was encapsulated to form AIE dots with biocompatibility and surface functionality. A cell-penetrating peptide derived from the HIV-1 transactivator of transcription protein (Tat) was further conjugated to the dot surface to generate AIE-Tat dots with high cellular internalization efficiency. AIE-Tat dots showed an emission maximum at 547 nm, similar to GFP, with a high quantum yield of 63%, and stable green fluorescence over 10 days under different pH conditions or long-term incubation in bu...

example 2

[0324] Specific light-up bioprobes with AIE and activatable photoactivity for targeted and image-guided photodynamic ablation of cancer cells

[0325] In another exemplary embodiment, the present invention is figure 2 Activatable photosensitizers for image-guided photodynamic ablation of cancer cells shown in A. figure 2 A shows the synthetic route of functionalizable TPE derivative TPECM-2N3 and biological probe TPECM-2GFLGD3-cRGD.

[0326] Cathepsin B is a lysosomal protease overexpressed in many types of tumors. It can specifically cleave substrates containing the -Gly-Phe-Leu-Gly-(GFLG) peptide sequence and has been used in enzyme-responsive drug delivery. On the other hand, cyclic arginine-glycine-aspartate (cRGD), which can selectively interact with avb3 integrin overexpressed in cancer cells, has been used for targeted drug delivery.

[0327] In an exemplary embodiment, the probe consists of four parts: 1) an AIE fluorescer with orange fluorescence as a contrast ag...

example 3

[0332] Combination of mitochondrial-targeted molecular probes with aggregation-induced luminescence-mediated image-guided chemotherapy and photodynamic therapy

[0333] In another exemplary embodiment, the invention is an AIE probe having zero, one or two triphenylphosphonium ligands, which is capable of selectively targeting mitochondria. An exemplary embodiment of a probe with zero triphenylphosphonium ligands is TPECM-2Br, which is represented by the following structure:

[0334]

[0335] TPECM-2Br

[0336] An exemplary embodiment of a probe with one triphenylphosphonium ligand is TPECM-ITPP, which is represented by the following structure:

[0337]

[0338] TPECM-1TPP

[0339] An exemplary embodiment of a probe with two triphenylphosphonium ligands is TPECM-1TPP, which is represented by the following structure:

[0340]

[0341] TPECM-2TPP

[0342] The synthetic route of above-mentioned compound is as follows Figure 5 shown.

[0343] Lipophilic triphenylpho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

A fluorophore or conjugated polymer with aggregation-induced emission characteristics useful for drug tracking and delivery, identification and labeling of biological subjects, such as cells or parts of a cell, as well as for imaging, and image-guided photodynamic therapy are described herein.

Description

[0001] related application [0002] This patent application covers the US provisional patent application, application number: 61 / 984,459, filed on April 25, 2014. The contents of the patent including English are listed below. [0003] Background of the invention [0004] In recent decades, fluorescence imaging has been widely used in various directions of biological science research, such as programmed cell apoptosis, organelle imaging, cell lineage transmission, etc. Compared with other imaging modalities including positron emission tomography (PET), magnetic resonance imaging, single photon emission computed tomography, etc., fluorescence imaging can obtain high signal-to-noise ratio at the subcellular level by using off-the-shelf biocompatible contrast agents imaging of cells, enabling the study of cell-cell interactions and immunological studies. In these bioimaging studies, real-time non-invasive fluorescence imaging over long periods of time is crucial for the study of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C15/52G01N33/52C09K11/06C07D285/14C07D309/34A61K31/015A61K31/282
CPCC07D309/34C07D285/14C09K11/06C09K2211/1007C09K2211/1014C09K2211/1051C09K2211/1088G01N33/582A61K41/0042A61K49/0056C07C255/43C09B23/0058C09B23/06C09B23/141C09B57/008C09B69/103C09B69/109C09K11/07A61K9/4866A61K2121/00A61K2123/00G01N33/5011
Inventor 刘斌袁友永冯光雪唐本忠秦伟张崇敬许适当
Owner NAT UNIV OF SINGAPORE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products